17 results
10-K
2023 FY
SLRN
Acelyrin Inc
28 Mar 24
Annual report
4:21pm
attacks by computer hackers, cracking, application security attacks, social engineering (including through deep fakes, which may be increasingly more
8-K
EX-99.3
SLRN
Acelyrin Inc
11 Mar 24
ACELYRIN, INC. Announces Positive Top-line Results from Its Global Phase 2b/3 Clinical Trial of Izokibep in Psoriatic Arthritis
8:05am
abscesses, inflammatory nodules, fistulae, scar tissue, malodor and pain, often resulting in permanent disfigurement and social stigma negatively impacting
10-Q
m2qe94myex
15 Jun 23
Quarterly report
4:19pm
424B4
jqvxq9xm vsky
5 May 23
Prospectus supplement with pricing info
4:22pm
S-1/A
EX-4.1
4k71jguq
1 May 23
IPO registration (amended)
6:10am
S-1/A
EX-10.3
y4k1k6qd05 vopwpa
1 May 23
IPO registration (amended)
6:10am
S-1/A
yml5w
1 May 23
IPO registration (amended)
6:10am
S-1/A
EX-10.6
lopqs5n
1 May 23
IPO registration (amended)
6:10am
S-1
EX-10.13
qti6phedb 1mh6blz
13 Apr 23
IPO registration
5:10pm
S-1
EX-2.1
p1l1ivq4ff hzqynyyw
13 Apr 23
IPO registration
5:10pm
S-1
EX-10.2
k45kg9m 0pw
13 Apr 23
IPO registration
5:10pm
S-1
ls7usbzyil
13 Apr 23
IPO registration
5:10pm
S-1
EX-10.12
ytd8 fy2finypw02zf27
13 Apr 23
IPO registration
5:10pm
- Prev
- 1
- Next